Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Om Dutt Sharma"'
Autor:
Nupur Das, Meetu Dahiya, Ritu Gupta, Lalit Kumar, Lata Rani, Anubha Gupta, Akanksha Farswan, Atul Sharma, Om Dutt Sharma
Publikováno v:
American Journal of Clinical Pathology. 159:69-80
Objectives With a substantial number of patients with multiple myeloma (MM) experiencing disease relapse, the quest for more sensitive methods to assess deeper responses indicative of cure continues. Methods In this prospective analysis of 170 patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::468534160e35049333f9e46e6fbf8bdc
https://doi.org/10.1093/ajcp/aqac129
https://doi.org/10.1093/ajcp/aqac129
Autor:
Lalit Kumar, Mohammad Mir Hussain, Rajegowda Chethan, Ranjit Kumar Sahoo, Prabhat S. Malik, Om Dutt Sharma, Anisha Mathew, Ankit Jha, Ritu Gupta, Atul Sharma, Ahitagni Biswas, Rakesh Kumar, Sanjay Thulkar, Soumyaranjan Malik, Ashish Dutt
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:e826-e835
Autologous stem cell transplant (ASCT) is a standard therapy for transplant eligible patients of multiple myeloma (MM). To evaluate impact of time to transplant on subsequent outcomes, we analyzed data on consecutive MM patients who received novel ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de4244dfd1efbb211b3f94447b8e99de
https://doi.org/10.1016/j.clml.2022.04.020
https://doi.org/10.1016/j.clml.2022.04.020
Autor:
Lalit, Kumar, Ranjit Kumar, Sahoo, Sudhir, Kumar, Annie K, Baa, Ghazal, Tansir, Neha, Pathak, Prabhat S, Malik, Om Dutt, Sharma, Anisha, Mathew, Ankit, Jha, Ritu, Gupta, Atul, Sharma, Ahitagni, Biswas, Rakesh, Kumar, Sanjay, Thulkar, Soumyaranjan, Malik, Ashish, Dutt
Publikováno v:
Leukemialymphoma.
We evaluated impact of melphalan dose on transplant outcomes for multiple myeloma. Between 1995 and 2019 459 consecutive patients received a transplant; 69(15%) received melphalan ≤150 mg/m2 (Mel 150 cohort) and 390 (85%) melphalan 200 mg/m2 (MEL 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::660eaa3961c56476be956645d4623838
https://pubmed.ncbi.nlm.nih.gov/36416679
https://pubmed.ncbi.nlm.nih.gov/36416679
Autor:
Om Dutt Sharma, Atul Sharma, Ritu Gupta, Lakshmy Ramakrishnan, Varun Shekhar, Meetu Dahiya, Lalit Kumar, Abida Begum
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:e345-e350
Background We sought to determine the prevalence of monoclonal gammopathy of undetermined significance (MGUS) in a hospital-based cohort in India. Patients and Methods From March 2015 to May 2015, 3429 patients (age range, 40-88 years) were enrolled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c747ec6b03e63cbe6823cacf86c217c0
https://doi.org/10.1016/j.clml.2018.06.005
https://doi.org/10.1016/j.clml.2018.06.005
Autor:
Sadaf Khan, Meetu Dahiya, Anjali Mookerjee, Nitin Mathur, Lata Rani, Lalit Kumar, Ritu Gupta, Atul Sharma, Om Dutt Sharma, Varun Shekhar, Gurvinder Kaur
Publikováno v:
Annals of Hematology. 97:2447-2454
The recently introduced Revised International Staging System (R-ISS) for multiple myeloma (MM) integrates albumin, β2 microglobulin, lactate dehydrogenase (LDH) with high-risk cytogenetic aberrations (CA), i.e., t(4;14) and t(14;16) and del17p using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23634c9f0e98c261ae71f39646ae0f53
https://doi.org/10.1007/s00277-018-3457-8
https://doi.org/10.1007/s00277-018-3457-8
Autor:
Om Dutt Sharma, Lalit Kumar, Meetu Dahiya, Ritu Gupta, Varun Shekhar, Atul Sharma, P. Harish, Nitin Mathur
Publikováno v:
Leukemia & Lymphoma. 58:1234-1237
The use of novel agents for the treatment of multiple myeloma (MM) has enabled attainment of deeper responses and the information that progression-free survival (PFS) and overall survival (OS) corr...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1a77cc71294edc2fdb8834e08decbfb
https://doi.org/10.1080/10428194.2016.1228930
https://doi.org/10.1080/10428194.2016.1228930
Autor:
Lata Rani, Anubha Gupta, Ritu Gupta, Nitin Mathur, Lalit Kumar, Vishwajeet Singh, Gurvinder Kaur, Om Dutt Sharma, Atul Sharma
Publikováno v:
Leukemia research. 76
Complex Chromosomal Rearrangements (CCRs) are increasingly being reported as genetic risk factors of clinical significance in cancer owing to their identification using high resolution whole genome profiling technologies. This study employed high res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3e060a963bb33373e35847e3e03b9de
https://pubmed.ncbi.nlm.nih.gov/30576858
https://pubmed.ncbi.nlm.nih.gov/30576858
Autor:
Lilit Atanesyan, Ritu Gupta, Maryvonne Steenkamer, Lata Rani, Jeroen B. van der Steen, Gurvinder Kaur, Om Dutt Sharma, Deepshi Thakral, Sadaf Khan, Suvi Savola, Lalit Kumar, Atul Sharma
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e66-e67
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf6570e99ec7fedd35432633c746bb4e
https://doi.org/10.1016/j.clml.2019.09.104
https://doi.org/10.1016/j.clml.2019.09.104
Autor:
Lalit Kumar, Om Dutt Sharma, Ritu Gupta, Santosh Kumar Chellapuram, Ranjit Kumar Sahoo, Anjali Mookerjee, Prabhat Singh Malik, Ahitagni Biswas
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e210-e211
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a0bfed9e6acbd0474a1e78bc0c88224
https://doi.org/10.1016/j.clml.2019.09.350
https://doi.org/10.1016/j.clml.2019.09.350
Autor:
Anubha Gupta, Lalit Kumar, Ritu Gupta, Saswati Hazra, Om Dutt Sharma, Gurvinder Kaur, Gurleen Kaur, Atul Sharma
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e207-e208
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7726ff61e7ca77175cdd4654ea17fc67
https://doi.org/10.1016/j.clml.2019.09.345
https://doi.org/10.1016/j.clml.2019.09.345